FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between DK Enterprises Global IPO and Nidan Laboratories and Healthcare IPO.
DK Enterprises Global IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Nidan Laboratories and Healthcare IPO is a SME Fixed Price Issue proposed to list at NSE SME.
DK Enterprises Global IPO | Nidan Laboratories and Healthcare IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Fixed Price Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | Beeline Broking Ltd | First Overseas Capital Limited |
Registrar | Skyline Financial Services Private Ltd | Bigshare Services Pvt Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of DK Enterprises Global IPO is up to ₹7.99 Cr whereas the issue size of the Nidan Laboratories and Healthcare IPO is up to ₹50.00 Cr. The final issue price of DK Enterprises Global IPO is ₹40.00 per share and of Nidan Laboratories and Healthcare IPO is ₹125.00 per share.
DK Enterprises Global IPO | Nidan Laboratories and Healthcare IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ||
Issue Price (Upper) | ||
Issue Price (Final) | ₹40.00 per share | ₹125.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 3000 shares | 1000 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | ||
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 19,98,000 shares | 40,00,000 shares |
Issue Size Total (Amount) | up to ₹7.99 Cr | up to ₹50.00 Cr |
DK Enterprises Global IPO opens on Oct 07, 2021, while Nidan Laboratories and Healthcare IPO opens on Oct 28, 2021. The closing date of DK Enterprises Global IPO and Nidan Laboratories and Healthcare IPO is Oct 12, 2021, and Nov 02, 2021, respectively.
DK Enterprises Global IPO | Nidan Laboratories and Healthcare IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Oct 07, 2021 | Oct 28, 2021 |
Issue Close | Oct 12, 2021 | Nov 02, 2021 |
Basis Of Allotment (Tentative) | Oct 18, 2021 | Nov 09, 2021 |
Initiation of Refunds (Tentative) | Oct 20, 2021 | Nov 10, 2021 |
Credit of Share (Tentative) | Oct 20, 2021 | Nov 11, 2021 |
Listing date (Tentative) | Oct 22, 2021 | Nov 12, 2021 |
Anchor Lockin End date 1 | Nov 17, 2021 | Dec 09, 2021 |
Anchor Lockin End date 2 | Jan 16, 2022 | Feb 07, 2022 |
DK Enterprises Global IPO P/E ratio is , as compared to Nidan Laboratories and Healthcare IPO P/E ratio of .
DK Enterprises Global IPO | Nidan Laboratories and Healthcare IPO | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 99.88% | 99.99% | ||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 73.30% | 71.22% | ||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the DK Enterprises Global IPO retail investors (RII) are offered 9,48,000 shares while in Nidan Laboratories and Healthcare IPO retail investors are offered 9,48,000 shares. Qualified institutional buyers (QIB) are offered in DK Enterprises Global IPO and in Nidan Laboratories and Healthcare IPO.
DK Enterprises Global IPO | Nidan Laboratories and Healthcare IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | 1,02,000 shares | 2,00,000 shares |
QIB | ||
NII | 9,48,000 shares | 19,00,000 shares |
RII | 9,48,000 shares | 19,00,000 shares |
Employee | ||
Others | ||
Total | 18,96,000 shares | 38,00,000 shares |
DK Enterprises Global IPO subscribed 12.50x in total, whereas Nidan Laboratories and Healthcare IPO subscribed 1.80x.
DK Enterprises Global IPO | Nidan Laboratories and Healthcare IPO | |
---|---|---|
QIB (times) | ||
NII (times) | 7.43x | 0.15x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 17.58x | 3.44x |
Employee (times) | ||
Other (times) | ||
Total (times) | 12.50x | 1.80x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|